Central Corneal Endothelial Cell Density and Central Corneal Thickness in Ocular Hypertension and Primary Open-Angle Glaucoma
Post on 25-Feb-2017
Embed Size (px)
CENTRAL CORNEAL ENDOTHELIAL CELL DENSITY AND CENTRALCORNEAL THICKNESS IN OCULAR HYPERTENSION AND PRIMARY
MICHAEL KOREY, M.D., DAVID GIESER, M.D., MICHAEL A. Kxss, M.D.,STEPHEN R. WALTMAN, M.D., MAE GORDON, PH.D.,
AND BERNARD BECKER, M.D.St. Louis, Missouri
In order to assess the effect of increased intraocular pressure on thecorneal endothelium, we classified 254 patients into four groups: Group1, those with normal intraocular pressures; Group 2, those withuntreated ocular hypertension; Group 3, those with treated ocularhypertension; and Group 4, those with primary open-angle glaucoma.One eye of each patient underwent specular microscopy and pachymet-ry. The eyes in the four groups did not differ significantly as to centralcorneal endothelial cell density or central corneal thickness. Thesemeasurements were not related to sex, race, or intraocular pressure (P> .12 in all cases). Increasing age was associated with a decrease incentral corneal endothelial cell density (P = .0(01), but was notassociated with a change in central corneal thickness (P = .22). Therewas no significant relationship between the use of topical ocularhypotensive medications and central corneal endothelial cell density (P= .38) or central corneal thickness (P = .07) in patients with ocularhypertension or primary open-angle glaucoma. Neither uncomplicatedperipheral iridectomy nor trabeculectomy produced significant changeswhen preoperative measurements were compared to measurementsmade 12 weeks postoperatively (P > .30 in all cases). Two eyes with flatanterior chambers following trabeculectomy had substantial decreasesin central corneal endothelial cell density.
There is evidence suggesting that in-creased intraocular pressure and medicaland surgical treatment of glaucoma canaffect the structure and function of thecorneal endothelium. Corneal edema oc-
Accepted for publication Aug. 13, 1982.From the Department of Ophthalmology, Wash-
ington University School of Medicine, St. Louis,Missouri. This study was supported in part by grantEY 00004 from the National Eye Institute and by anunrestricted grant from Research to Prevent Blind-ness, Inc., New York, New York.
Reprint requests to Michael A. Kass, M.D., De-partment of Ophthalmology, Washington UniversitySchool of Medicine, 660 S. Euclid Ave., St. Louis,MO 63110.
curs in some eyes with glaucoma, particu-larly in eyes that experience a rapid andmarked increase in intraocular pressure.Decreased central corneal endothelialcell density occurs in eyes with acuteangle-closure glaucoma.P glaucomato-cyclitic crisis," and glaucoma capsulare."Experimentally induced ocular hyperten-sion produces morphologic changes inrabbit! and monkey'' corneal endotheliumthat may be associated with decreasedcorneal clarity and increased central cor-neal thlckness.F' Topical or intracameraladministration of ocular hypotensivemedications and their preservatives candamage the corneal endothelium in
610 AMERICAN JOURNAL OF OPHTHALMOLOGY 94:610-616, 1982
VOL. 94, NO.5 CORNEAL ENDOTHELIUM 611
human and animal eyes.r" Peripheral iri-dectomy and trabeculectomy can producea decrease in central corneal endothelialcell density. 1 Although these reports sug-gest that increased intraocular pressureand antiglaucoma treatment can have ad-verse effects on the corneal endothelium,there are no published studies evaluatingthese matters systematically.
612 AMERICAN JOURNAL OF OPHTHALMOLOGY NOVEMBER, 1982
OCULAR HYPOTENSIVE MEDICATIONS
*Some patients received more than one medica-tion.
optic disks, and normal visual fields. Themean intraocular pressure for a givenpatient included all values recorded dur-ing follow-up for that individual. Thesepatients had not used ocular hypotensivemedication at any time. Group 3--Another 35 patients with ocular hyper-tension (classified by the same criteria asGroup 2) had received topical ocular hy-potensive medication. Table 2 shows thedrugs used and the duration of therapy.The mean intraocular pressure record fora subject who had received ocular hypo-tensive therapy included both treatedand untreated measurements in order toreflect the intraocular pressures to whichthe cornea had been exposed over a peri-od of time. Group 4-We classified 54patients as having primary open-angleglaucoma on the basis of mean untreatedintraocular pressures of 21 mm Hg orhigher, open angles on gonioscopy, andtypical glaucomatous optic disk cuppingand visual field loss. Table 2 showsthe topical ocular hypotensive agentsused and the duration of therapy. Themean intraocular pressure for a givenpatient included both treated and un-treated measurements during the follow-up period.
We also studied 23 patients scheduled
for glaucoma surgery prospectively. Sev-enteen patients (18 eyes) had uncon-trolled open-angle glaucoma (14 primaryopen-angle glaucoma, two pigmentaryglaucoma, and one posttraumatic anglerecession) necessitating filtering surgery.Excisional trabeculectomies were per-formed anterior to the scleral spur. Sixpatients (eight eyes) scheduled for pe-ripheral iridectomy were also studiedprospectively. Seven eyes underwentsurgical iridectomy for chronic angle-closure glaucoma and one eye had a pro-phylactic iridectomy.
We excluded all eyes with a history orfindings of previous corneal disease, ocu-lar inflammation, ocular trauma, or ocularsurgery. (The exclusion criteria of previ-ous ocular surgery or ocular trauma didnot apply to eyes undergoing trabeculec-tomy.) Eyes undergoing iridectomy wereexcluded from the study if there wasevidence of previous attacks of acuteangle-closure glaucoma, including glau-comflecken, sector iris atrophy, periph-eral anterior synechiae, and posteriorsynechiae.
Central corneal thickness was mea-sured in a masked fashion with a pachy-meter mounted on a slit lamp as de-scribed by Mishima and Hedbys." Threemeasurements of central corneal thick-ness were obtained, recorded to the near-est 0.01 rnm, and averaged.
Specular microscopy was performed bythe method of Waltman and associates."Five photographs were taken of the cen-tral corneal endothelium before any pro-cedure that might affect corneal clarity.The photographs were analyzed in amasked fashion with a rho-theta plottingdevice interfaced to a minicomputer viaan analog-to-digital converter. Twenty to50 cells were traced on each photograph.The total area of the cells traced wascalculated to yield a mean cell area whichwas converted to a mean endothelial celldensity per square millimeter.
32.8 27.614.9 23.418.6 32.7
2.0 0.042.1 36.410.8 9.410.4 8.919.5 19.014.2 15.5
Duration ofTherapy (mos)(Mean S.D.)
No. ofMedication Patients*
Pilocarpine 62Carbachol 22Echothiophate iodide 14Demecarium bromide 2Epinephrine 73Dipivefrin 16Timolol 59Acetazolamide 29Methazolamide 25
VOL. 94, NO. 5 CORNEAL ENDOTHELIUM 613
Central corneal endothelial cell densityand central corneal thickness were mea-sured in all patients. Additionally, pa-tients undergoing glaucoma surgery hadpachymetry and specular microscopyperformed before surgery and again 12weeks postoperatively.
We conducted a test-retest reliabilitystudy to evaluate how much of the varia-bility in central corneal endothelial celldensity between individuals was the re-sult of measurement variability. Each eyeof 22 normal volunteers was photo-graphed in two sessions. The technicianperformed the cell counts in a maskedfashion. Test-retest reliability was esti-mated with an intraclass correlation coef-ficient in which variability resulting fromphotography, technician, and the interac-tion of these sources with the subjectwere included in the error term. Theintraclass correlation was .93, suggestingthat the variability observed between in-dividuals was not affected substantially bymeasurement variability. The mean per-centage difference between the centralcorneal endothelial cell densities record-ed at the first and the second sessions forthe same eye was 5.6% 5.4% (range,0.2% to 19.7%). The difference betweenthe two measurements was more than10% in seven of 44 eyes (15%).
Neither mean central corneal endothe-lial cell density nor central corneal thick-ness differed significantly among the fourgroups (Table 1). We evaluated the effectsof age, sex, race, and intraocular pressurein each group and in the combined sam-ple with a linear regression model. Theinfluence of each factor was consideredalone as well as in combination with theother factors. Increasing age was associat-ed with a decrease in central cornealendothelial cell density (r = -.31; P =.0001) but was not associated with a
change in central corneal thickness (P =.22). Sex, race, and intraocular pressures(both mean values and those obtained onthe day of pachymetry and specular mi-croscopy) were not related significantly tocentral corneal endothelial cell density(P > .12 in all cases) or to central cornealthickness (P > .28 in all cases).
To further assess the effect of intraocu-lar pressure, we compared Group 1 toGroup 2. There was no substantial differ-ence between the two groups with re-spect to central corneal endothelial celldensity (P = .10) or central corneal thick-ness (P = .69) after controlling for theeffects of age.
Group 1 and Group 4 did not differwith respect to central corneal endotheli-al cell density (P = .53) or central cornealthickness (P = .19) after controlling forthe effects of age.
We assessed the possible effect of topi-cal ocular hypotensive medication in twoways. (1) We compared Group 2 to Group3. After controlling for the effects of age,there was no significant difference be-tween the two groups with respect tocentral corneal endothelial cell density(P = .38) or central corneal thickness(P = .